Gastro Meeting 2017

Theme: Novel Innovations in Gastroenterology

Market Analysis:

Gastro meetings

Theme: Novel Innovations In Gastroenterology

Meetings International will be holding its Global Experts Meeting entitled Focus on Gastroenterology from November 13-15, 2017. The theme of this year’s meeting is “Novel Innovations In Gastroenterology" which will provide an international platform for discussion of present and future challenges in Gastroenterology. World-leading practitioners, clinicians, educators and researchers will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.

Importance & Scope:

Gastroenterology is the branch of medical sciences which deals with the path of logistic study, prevention and management of diseases related to livergall bladder, biliary tree and pancreas.

Gastroenterology Meeting 2017 welcomes attendees, presenters, and exhibitors from all over the world to Melbourne, Australia. And we are delighted to invite you all to attend and register for the Asia-Pacific meeting on Gastroenterology which is going to be held during November 13-15, 2017, Melbourne, Australia. The organizing committee is gearing up for the  exciting and the  informative conference program including plenary lectures, symposia, workshops on different  topics, poster presentations and various programs for participants around the world. We invite you to join us at the Gastroenterology meeting 2017, where you will sure have a meaningful experience with all the scholars from around the world and also the members of Gastroenterology 2017 organizing committee look forward to meet you at Melbourne, Australia.
 
Current Market statistics:
 
According to the new market research report, "Gastrointestinal Diseases Market, by Drug Category - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", the gastrointestinal diseases market was grown from USD 19.79 billion in 2016 and then  reach USD 20.68 billion by 2022, growing at a CAGR of 2.3% during forecast period.

The global gastrointestinal market report offers the in-depth analysis of the revenue, market share, major market segments, different geographic regions, key players, premium trends and forecasts to 2022. It also focuses on the key drivers and also on opportunities in this market

Why Asia?

Gastroenterology in Asia will increase and expand its market share. The drivers behind the expansion are two-fold: first the expansion of local companies in Asia and secondly, Western pharma outsourcing its research and manufacturing operations to Asia, particularly China and India.

Conference Highlights: 

·         Gastrointestinal Advanced Treatment Procedure

·         New Biology of Gastrointestinal Hormones

·         Digestive Diseases

·         Advances in Liver Diseases

·         Future of Endoscopy in Gastroenterology

·         Gastroesophageal Reflux  Disease (GERD)

·         Gastrointestinal Oncology

·         Pancreatic Disease

·         Liver Fibrosis

·         Inflammatory Bowel Disease

·         Neuro Gastroenterology

·         Probiotics in Gastrointestinal Disorders

Why to attend???

Gastroenterology Meeting 2017 provides a valuable opportunity to stay up-to-date and ahead on the legislation and latest innovations. Unrivalled opportunity to do business and network with thousands of senior decision makers looking to discover the latest benefits and solutions to engage their staff.  Conduct meetings with current and potential scientists, distribute information, presentations, make a splash with new developments, and receive name recognition at this 3-day event. World-renowned speakers, developments, the most recent techniques, and the newest updates in separation techniques are hallmarks of this conference.       

A Unique Opportunity for Advertisers and Sponsors at this International event:

Major Worldwide Gastroenterology Organizations:

Emirats gastroenterology and Hepatology Society(EGHS)

European association for the study of the liver

The International association for the study of the liver

The Saudi society of Peadiatric Gastroenterology, Hepatology and Nutrition(saspghan)

The Pan Arab society of Pediatric Gastroenterology, Hepatology and Nutrition (PASPGHAN))

The Japan Society of Hepatology

The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria (ESHGID)

The Egyptian Hepato-Pancreato-Biliary Society

Hepatology Society of the Philippines

Gastroenterology Associated Universities

In Melbourne:

University of Melbourne

 

Central Melbourne Gastroenterology

Melbourne GI and Endoscopy

Melbourne Gastrointestinal Group

Monash University Clayton Campus

The Royal Melbourne Hospital

Gow Paul

   
     

Companies Associated with Gastroenterology

3M Pharmaceuticals Pty Ltd

 

Abbott Australasia Pty Ltd

 

Alcon Laboratories Pty Ltd

 

Allergan Australia Pty Ltd

 

Alphapharm Pty. Ltd

   

Altana Pharma Pty. Ltd.

 

Amersham Health Pty Limited

Amgen Australia Pty Ltd

 

AstraZeneca Pty Ltd

   

Aurora BioScience Pty. Ltd.

 

Australian Radioisotopes

 

AVENTIS PASTEUR Pty Ltd

 

AZA Research Pty Ltd

 

Bausch & Lomb Australia Pty. Ltd.

Baxter Healthcare Pty. Ltd.

 

Bayer Australia Ltd

   

BD (Becton Dickinson)

 

Biochemie Australia Pty Ltd

 

Biochemie Australia Pty Ltd

 

Biogen Australia Pty Ltd

 

Boehringer Ingelheim Pty Ltd

Boots Healthcare Australia Pty Ltd

Boron Molecular Limited

 

Boucher & Muir Pty Ltd

 

Bristol-Myers Squibb Australia Pty Ltd

CSL Limited

   

Douglas Pharmaceuticals

 

Eli Lilly Australia Pty Ltd

 

Faulding Pharmaceuticals

 

GlaxoSmithKline Australia

 

Hamilton Pharmaceuticals Pty Ltd

Hoechst Marion Roussel Australia Pty Ltd

Leo Pharmaceutical Products Ltd

Leo Pharmaceutical Products Ltd

Novo Nordisk Pharmaceuticals Pty Ltd

Otsuka Pharmaceutical Australia Pty Ltd

Pfizer Pty Ltd

   

 Evolution of HCV Therapy:

In the United States, 20 percent to 30 percent of people living with HIV are coinfected with HCV. Hepatitis C is common among people living with HIV. This means that about 225,000 to 330,000 people in the United States are living with both viruses. The majority of people living with hepatitis C do not know they have it. The most common route of transmission in the UK is using non-sterile needles and other equipment for injecting drugs. 90 percent of people who got HIV from injecting drugs are also infected with HCV. This is because both viruses can be spread easily through blood and blood products.

 

  • Gastrointestinal Advanced Treatment Procedure
  • New Biology of Gastrointestinal Hormones
  • Digestive Diseases
  • Future Trends In Treating Liver Diseases
  • Future Of Endoscopy In Gastroenterology
  • Gastroesophageal Reflux Disease
  • Gastrointestinal Oncology
  • Pancreatic Disease
  • Liver Fibrosis
  • Probiotics in gastrointestinal disorders
  • Complementary and alternative medicine for Gastroenterology
  • Inflammatory bowel disease
  • Neuro-Gasteroenterology